KRAS G12D -Specific Targeting with Engineered Exosomes Reprograms the Immune Microenvironment to Enable Efficacy of Immune Checkpoint Therapy in PDAC Patients

Valerie S. LeBleu(The University of Texas MD Anderson Cancer Center), Shubham Pant(The University of Texas MD Anderson Cancer Center)

medRxiv

March 6, 2025

Cited by 16

|Nature|2015|2.9k

|Science|2009|422

|Journal of Proteome Research|2015|75

|Nature Communications|2025|28

KRAS <sup>G12D</sup> -Specific Targeting with Engineered Exosomes Reprograms the Immune Microenvironment to Enable Efficacy of Immune Checkpoint Therapy in PDAC Patients